RT Journal Article
SR Electronic
T1 Supporting Austria through the COVID-19 Epidemics with a Forecast-Based Early Warning System
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.18.20214767
DO 10.1101/2020.10.18.20214767
A1 Martin Bicher
A1 Martin Zuba
A1 Lukas Rainer
A1 Florian Bachner
A1 Claire Rippinger
A1 Herwig Ostermann
A1 Nikolas Popper
A1 Stefan Thurner
A1 Peter Klimek
YR 2020
UL http://medrxiv.org/content/early/2020/10/20/2020.10.18.20214767.1.abstract
AB Background The corona crisis hit Austria at the end of February 2020 with one of the first European superspreading events. In response, the governmental crisis unit commissioned a forecast consortium with regularly projections of case numbers and demand for hospital beds.Methods We consolidated the output of three independent epidemiological models (ranging from agent-based micro simulation to parsimonious compartmental models) and published weekly short-term forecasts for the number of confirmed cases as well as estimates and upper bounds for the required hospital beds.Findings Here, we report om four key contributions by which our forecasting and reporting system has helped shaping Austria’s policy to navigate the crisis and re-open the country step-wise, namely (i) when and where case numbers are expected to peak during the first wave, (ii) how to safely re-open the country after passing this peak, (iii) how to evaluate the effects of non-pharmaceutical interventions and (iv) provide hospital managers guidance to plan health-care capacities.Interpretation Complex mathematical epidemiological models play an important role in guiding governmental responses during pandemic crises, provided they are used as a monitoring system to detect epidemiological change points. For policy-makers, the media and the public, it might be problematic to distinguish short-term forecasts from worst-case scenarios with undefined levels of certainty, creating distrust in the legitimacy and accuracy of such models. However, when used as a short-term forecast-based monitoring system, the models can inform decisions to ease or strengthen governmental responses.Competing Interest StatementThe authors have declared no competing interest.Funding StatementOur work as COVID-19 Forecast Consortium was financially supported by the Federal Ministry for Social Affairs, Health, Care and Consumer Protection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available online. https://www.data.gv.at/covid-19/